A Randomized, Double-blind, 52-week, Placebo Controlled Efficacy and Safety Study of Dupilumab, in Patients With Bilateral Nasal Polyposis on a Background Therapy With Intranasal Corticosteroids
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Dupilumab (Primary) ; Mometasone
- Indications Nasal polyps
- Focus Therapeutic Use
- Acronyms SINUS-52
- Sponsors Sanofi
- 30 Nov 2016 Status changed from not yet recruiting to recruiting.
- 28 Nov 2016 Planned primary completion date changed from 1 Jul 2018 to 1 Dec 2018.
- 21 Nov 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Jul 2018.